+ Chinese + English

首页关于格然林 | 新闻中心 | 服务与产品 | 文献知识库 | 基础设施 | 企业文化与人才 | 联系我们 |

药物开发服务

产品与服务信息

Carbohydrate Derivatives

Nucleosides and Reagents

Super-chelating Agents & MRI Contrast Agents

Heterocyclic Compounds

Intermediate & Building Blocks

Formulation Products and Drugs substances

Flavoring, Additives and Agricultural Products

Fire Retardants

Metal complexes

Bio-reagents and conjugation reagents

0371-6711 0368

Nucleosides and Reagents

首页 > 服务与产品 > Nucleosides and Reagents > 5-Modified pyrimidine nucleosides

GL100815 POST:2014-01-24
GL100814 POST:2014-01-24
GL100808 POST:2014-01-24
GL100809 POST:2013-12-31
GL100804 POST:2013-12-31
GL100805 POST:2013-12-31
GL100799 POST:2013-12-31
GL100798 POST:2013-12-31
GL100821 POST:2013-12-31
GL100820 POST:2013-12-31
GL100819 POST:2013-12-31
GL100818 POST:2013-12-31
GL100793 POST:2013-12-31
GL100792 POST:2013-12-31
GL100388 POST:2013-06-15
GL100725 POST:2013-06-15
GL100724 POST:2013-06-15
GL100723 POST:2013-06-15
GL100722 POST:2013-06-15
GL100718 POST:2013-06-15
GL100614 POST:2013-06-02
GL100362 POST:2013-05-31
GL100361 POST:2013-05-31
GL100532 POST:2013-05-31
GL100529 POST:2013-05-31
GL100430 POST:2013-05-31
GL100390 POST:2012-11-13
GL100387 POST:2012-11-13
GL100385 POST:2012-11-13
GL100383 POST:2012-11-13
GL100382 POST:2012-11-13
GL100359 POST:2012-11-13

CurrentPage:1/2 [1] [2]

: 关于格然林 | 新闻中心 | 服务与产品 | 文献知识库 | 基础设施 | 企业文化与人才 | 联系我们 |

© 1998 - 2022 Granlen Inc. 保留所有权利豫ICP备19022032号-1